Jing He, MD, PhDHead, Roche Pharma Development China at Roche
.Jing He is a trained medical oncologist. She got her MD inP Xi'an Medical University and Ph.D in Cancer Hospital of Chinese Academy of Medical Science. She had 8 years of clinical practice in medical oncology before joining Roche in 2006. She has directly contributed to the approval of Herceptin in adjuvant breast cancer and Avastin in multiple indications including mCRC and NSCLC. In 2015, Jing has been appointed as Global Development Team Lead for oncology and moved to South San Francisco, where she has led cross functional team to create and implement clinical development plan for a few oncology molecule. Jing was newly appointed as the Head of Roche Pharma Development in Shanghai and moved back in July 2018.